La Jolla Pharmaceutical Company

Receive alerts:
by e-mail
E-mail Your information will be added to a database with the sole purpose of serving your subscription. This database is the exclusive property of vLex Networks S.L. and will never be shared with any other company. By sending your request you accept the Data Protection Policy of vLex Networks S.L. I have read and accept the Terms of Use
via RSS

1.371 documents for La Jolla Pharmaceutical Company

- La Jolla Pharmaceutical Company to Focus on Regenerative Medicine with the Acquisition of Novel Class of Compounds.
Regenerative Immunophilin Ligands May Have Potential in a Broad Range of Indications, Including Scar Remodeling, Pulmonary Fibrosis and Myocardial Inf...
- Business Wire
- April 05, 2011
- La Jolla Pharmaceutical Company Announces Filing of Joint Proxy Statement/Prospectus.
SAN DIEGO -- La Jolla Pharmaceutical Company (NASDAQ: LJPC) ("La Jolla") today announced that it has filed its Registration Statement on Form S-4 with...
- Business Wire
- December 22, 2009
- La Jolla Pharmaceutical Company Announces Signing of Definitive Merger Agreement With Adamis Pharmaceuticals.
SAN DIEGO -- La Jolla Pharmaceutical Company (NASDAQ: LJPC) ("La Jolla") today announced that it entered into a definitive merger agreement with Adami...
- Business Wire
- December 07, 2009

- La Jolla Pharmaceutical Company Provides Responses to Frequently Asked Questions about Merger Vote.
SAN DIEGO -- La Jolla Pharmaceutical Company (NASDAQ: LJPC) today provided responses to frequently asked questions regarding the Company's upcoming sp...
- Business Wire
- February 19, 2010
- LA JOLLA PHARMACEUTICAL COMPANY ANNOUNCES FINANCING OF UP TO $16.3 MILLION.
Proceeds to Be Used to Pursue Pipeline Development and Potential Development Opportunities for Riquent[R] SAN DIEGO -- La Jolla Pharmaceutical Compa...
- Business Wire
- May 25, 2010
- La Jolla Pharmaceutical Company Announces Reverse Stock Split.
SAN DIEGO -- La Jolla Pharmaceutical Company (OTCBB:LJPC), a biopharmaceutical company dedicated to improving and preserving human life by acquiring a...
- Business Wire
- April 13, 2011
- La Jolla Pharmaceutical Company Reports First Quarter Financial Results.
SAN DIEGO -- La Jolla Pharmaceutical Company (Nasdaq: LJPC) reported a net loss for the three months ended March 31, 2008 of $13.6 million, or $0.34 p...
- Business Wire
- May 01, 2008
- La Jolla Pharmaceutical Company Provides Update on Search for Clinical Products to In-License or Acquire.
SAN DIEGO -- La Jolla Pharmaceutical Company (OTCBB:LJPC) (the "Company") provided an update today that the Company is actively seeking and evaluating...
- Business Wire
- September 07, 2010
- La Jolla Pharmaceutical Company Reports Third Quarter and Year-to-Date Financial Results.
SAN DIEGO -- La Jolla Pharmaceutical Company (Nasdaq: LJPC) reported a net loss for the three months ended September 30, 2008 of $17.1 million, or $0....
- Business Wire
- October 31, 2008
- La Jolla Pharmaceutical Company Reports Progress in International Phase 3 Riquent(R) Study.
SAN DIEGO -- La Jolla Pharmaceutical Company (Nasdaq:LJPC) today announced significant progress in its ongoing double-blind, placebo-controlled random...
- Business Wire
- February 11, 2008